The Heart Failure Efficacy and Research Trial (HEART) Platform is a multicenter, randomized clinical trial infrastructure designed to improve outcomes for heart failure patients.
Administered by the Canadian VIGOUR Centre (CVC), the HEART Platform Clinical Research Fellowship provides essential financial support to University of Alberta graduate trainees dedicated to advancing cardiovascular care. The program is specifically tailored for scholars focused on the design, implementation, and evaluation of clinical trials. Under the mentorship of CVC faculty, fellows engage in high-impact initiatives aimed at directly elevating the standards of cardiovascular medicine.
Eligibility:
- Registered (or confirmed eligible) for a full-time, thesis-based graduate program (Masters or PhD) in a health-related discipline, or in a medical residency at the University of Alberta at the time of application.
- Currently engaged in research relevant to the design, implementation, or evaluation of clinical trials that enhance cardiovascular clinical care.
Restrictions:
- Applicants must not have exceeded two years of Master’s study or five years of PhD study at the time of the application deadline (excluding official leaves of absence).
- This fellowship cannot be held in conjunction with any other full stipend award of equal or greater value. However, successful applicants are encouraged to apply for alternate or supplementary funding.
Program Length:
- 12-month term, starting September 2026 (or earlier depending on availability).
Funding:
- Each fellowship is valued up to $50,000 annually, and issued as a monthly bursary based on University and Research Administration Services (RAS) policies and procedures.
Application Deadline:
- Wednesday July 15, 2026 | 11:59 PM MST
